Lincoln International, Inc. Class A LCLN 深 滬
等待開盤 09-25 09:30:00 美东时间
23.14
-0.810
-3.38%
華盛通- 最 高23.88
- 今 開23.88
- 成交量 47.54万股
- 最 低 22.975
- 昨 收 23.95
- 總市值 23.65亿
- 52周最高 27.55
- 市盈率 靜 11.02
- 換手率 0.47%
- 52周最低 19.9801
- 委 比 -25.00%
- 總股本 1.02亿
- 歷史最高 27.55
- 量 比 0.27
- 振 幅 3.78%
- 歷史最低 19.9801
- 每 手 1
- 風險率 1.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 业绩大超预期！ CoreWeave、超微电脑、Lumentum绩后获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从49美元升至56美元；韦德布什：维持Zura Bio"跑赢大市"评级，目标价从15美元升至22美元
08-13 11:44
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
Keefe, Bruyette & Woods Maintains Market Perform on Lincoln International, Raises Price Target to $25
Keefe, Bruyette & Woods analyst Alex Bond maintains Lincoln International (NYSE:LCLN) with a Market Perform and raises the price target from $24 to $25.
08-10 22:38
Lincoln International Q2 Adj. EPS $0.26 Beats $0.13 Estimate, Sales $225.693M Beat $164.708M Estimate
Lincoln International (NYSE:LCLN) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.13 by 100 percent. The company reported quarterly sales of $225.693 million which beat the analyst consensus estimate of $164.708 million by 37.03 percent. This is a 50.81...
08-06 18:57
美股大行评级 | 潜在涨幅98.68%！DA Davidson上调Almonty Industries目标价至33美元，维持"买入"评级
今日重点评级关注：DA Davidson：维持Almonty Industries"买入"评级，目标价从25美元升至33美元；Stifel：维持Nurix Therapeutics"买入"评级，目标价从34美元升至40美元
07-13 10:13
Keefe, Bruyette & Woods Maintains Market Perform on Lincoln International, Lowers Price Target to $24
Keefe, Bruyette & Woods analyst Alex Bond maintains Lincoln International (NYSE:LCLN) with a Market Perform and lowers the price target from $26 to $24.
07-10 19:23
美股大行评级 | 大摩再上调希捷科技和西部数据目标价；多家大行首予Lincoln买入评级
今日重点评级关注：HC Wainwright & Co.：维持Elicio Therapeutics"买入"评级，目标价从17美元升至23美元；Leerink Partners：维持SAB Biotherapeutics"跑赢大市"评级，目标价从7美元升至12美元
06-16 11:34
Evercore ISI Group Initiates Coverage On Lincoln International with In-Line Rating, Announces Price Target of $25
Evercore ISI Group analyst Benjamin Rubin initiates coverage on Lincoln International (NYSE:LCLN) with a In-Line rating and announces Price Target of $25.
06-15 20:25
首日收盘|Optimi Health收涨2485.03%，最新总市值0.35亿美元
Optimi Health涨2485.03%，最新市值0.35亿美元；Lincoln International涨12.60%，最新市值22.97亿美元；Research Alliance III涨3.00%，最新市值0.94亿美元；AMASS Brands (Direct Listing)跌33.24%，最新市值1.27亿美元；
05-21 06:00
Lincoln International stock opens ~13% higher after IPO
Lincoln International (LCLN) stock jumped to $22.51 in its opening trade, or almost 13% above its initial public offering price of $20 on Wednesday. By ~1:38 PM ET, the shares rose 14% to $22.78. The ...
05-21 01:41
